Journal article

Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea

Jutta Marfurt, Ivo Mueeller, Albert Sie, Peter Maku, Mary Goroti, John C Reeder, Hans-Peter Beck, Blaise Genton

American Journal of Tropical Medicine and Hygiene | AMER SOC TROP MED & HYGIENE | Published : 2007

Abstract

Because of increasing resistance to 4-aminoquinolines in Papua New Guinea, combination therapy of amodiaquine (AQ) or chloroquine (CQ) plus sulfadoxine-pyrimethamine (SP) was introduced as first-line treatment against uncomplicated malaria in 2000. The purpose of this study was to monitor in vivo efficacy of the current standard combination therapy against Plasmodium falciparum and P. vivax malaria. Studies were conducted between 2003 and 2005 in the Simbu, East Sepik, and Madang Provinces in Papua New Guinea according to the revised protocol of the World Health Organization (WHO) for assessment of antimalarial drug efficacy. Children between six months and seven years of age with clinically..

View full abstract

University of Melbourne Researchers